Published in Medicine (Baltimore) on April 01, 2017
An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis (1980) 14.25
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA (2004) 10.40
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS (2006) 5.58
Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol (1982) 4.36
The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol (2002) 3.71
Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab (2008) 3.64
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS (2000) 3.39
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis (2010) 3.37
Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr (2007) 3.24
Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs (2006) 2.89
State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem (2012) 2.87
Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med (2001) 2.81
Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr (2009) 2.75
Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis (2010) 2.20
Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis (2003) 2.20
Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One (2011) 2.11
State-specific secondhand smoke exposure and current cigarette smoking among adults - United States, 2008. MMWR Morb Mortal Wkly Rep (2009) 2.11
Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. AIDS (2008) 2.01
Continuous antiretroviral therapy decreases bone mineral density. AIDS (2009) 1.96
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS (2003) 1.89
Short-term bone loss in HIV-infected premenopausal women. J Acquir Immune Defic Syndr (2010) 1.87
Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis (2011) 1.83
Longitudinal analysis of bone density in human immunodeficiency virus-infected women. J Clin Endocrinol Metab (2006) 1.72
Effects of beer, wine, and liquor intakes on bone mineral density in older men and women. Am J Clin Nutr (2009) 1.70
Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss. Nat Commun (2015) 1.63
Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS (2001) 1.50
Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med (2008) 1.46
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults. AIDS (2009) 1.46
Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study. AIDS (2012) 1.45
Validity of the lifetime drinking history: a comparison of retrospective and prospective quantity-frequency measures. J Stud Alcohol Drugs (2009) 1.41
Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend (2006) 1.32
High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS (2010) 1.30
Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res (2005) 1.27
Drinking patterns, dependency and life-time drinking history in alcohol-related liver disease. Addiction (2008) 1.25
Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies. J Infect Dis (2012) 1.22
Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure prophylaxis with tenofovir-emtricitabine or placebo in Botswana. PLoS One (2014) 1.12
HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development. AIDS Res Hum Retroviruses (2007) 1.11
Alcohol intake and its relationship with bone mineral density, falls, and fracture risk in older men. J Am Geriatr Soc (2006) 1.11
Validation of three food frequency questionnaires to assess dietary calcium intake in adults. J Am Diet Assoc (2007) 1.10
Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years. Clin Endocrinol (Oxf) (2007) 1.08
Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS (2010) 1.06
Alcohol consumption, bone density, and hip fracture among older adults: the cardiovascular health study. Osteoporos Int (2007) 1.04
Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems? Osteoporos Int (2009) 1.04
Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. PLoS Pathog (2014) 1.03
High prevalence of reduced bone mineral density in primary HIV-1-infected men. AIDS (2010) 1.02
Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis (2015) 0.99
Moderate alcohol consumption and bone density among postmenopausal women. J Womens Health (1999) 0.99
Osteopenia in alcoholics: effect of alcohol abstinence. Alcohol Alcohol (2009) 0.98
The role of HIV and antiretroviral therapy in bone disease. AIDS Rev (2011) 0.97
A prospective study of alcohol consumption and HIV acquisition among injection drug users. AIDS (2011) 0.96
Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin Infect Dis (2003) 0.95
Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2015) 0.94
Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. Drug Alcohol Depend (2016) 0.93
Low serum osteocalcin in acute alcohol intoxication: a direct toxic effect of alcohol on osteoblasts. Bone Miner (1987) 0.91
Ethanol inhibits human bone cell proliferation and function in vitro. Metabolism (1991) 0.91
Relative contribution of HIV infection, demographics and body mass index to bone mineral density. AIDS (2014) 0.90
Low bone mineral density in patients with well-suppressed HIV infection: association with body weight, smoking, and prior advanced HIV disease. J Infect Dis (2014) 0.90
Ethanol and acetaldehyde inhibit the formation of early osteoblast progenitors in murine and human bone marrow cultures. Alcohol Clin Exp Res (1999) 0.89
High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy. AIDS Res Hum Retroviruses (2015) 0.87
Low bone mineral density and risk of incident fracture in HIV-infected adults. Antivir Ther (2015) 0.87
Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study. AIDS (2014) 0.87
Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk? J Infect Dis (2014) 0.83
Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients. Osteoporos Int (2013) 0.82
Lifetime drinking trajectories among veterans in treatment for HIV. Alcohol Clin Exp Res (2013) 0.81
Vitamin D and bone loss in HIV. Curr Opin HIV AIDS (2016) 0.78
Tenofovir and bone health. Curr Opin HIV AIDS (2016) 0.78
Bone changes in alcoholic liver disease. World J Hepatol (2015) 0.78
The protease inhibitors and HIV-associated bone loss. Curr Opin HIV AIDS (2016) 0.78
Aging, human immunodeficiency virus, and bone health. Clin Interv Aging (2010) 0.78
Editorial: Working towards an understanding of bone disease in HIV. Curr Opin HIV AIDS (2016) 0.76
Vitamin D, bone, and HIV infection. Top Antivir Med (2012) 0.76
Estimates of optimal vitamin D status. Osteoporos Int (2005) 7.13
Age at drinking onset and alcohol dependence: age at onset, duration, and severity. Arch Pediatr Adolesc Med (2006) 7.10
Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr (2003) 6.50
The role of vitamin D in cancer prevention. Am J Public Health (2005) 4.99
Brief intervention for medical inpatients with unhealthy alcohol use: a randomized, controlled trial. Ann Intern Med (2007) 4.73
Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol (2008) 4.72
The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36
Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab (2007) 4.16
Confounding and studies of 'moderate' alcohol consumption: the case of drinking frequency and implications for low-risk drinking guidelines. Addiction (2012) 3.92
Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr (2007) 3.24
Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health (2009) 2.99
Vitamin D deficiency: what a pain it is. Mayo Clin Proc (2003) 2.90
Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev (2013) 2.87
Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med (2007) 2.83
Vitamin D insufficiency among free-living healthy young adults. Am J Med (2002) 2.80
Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med (2004) 2.72
Sleep-disordered breathing symptoms are associated with poorer cognitive function in 5-year-old children. J Pediatr (2004) 2.71
Primary care validation of a single-question alcohol screening test. J Gen Intern Med (2009) 2.66
Early age of first drunkenness as a factor in college students' unplanned and unprotected sex attributable to drinking. Pediatrics (2003) 2.60
Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Manag Care (2007) 2.60
Prevention of fatal opioid overdose. JAMA (2012) 2.53
Vitamin D deficiency in a healthy group of mothers and newborn infants. Clin Pediatr (Phila) (2007) 2.43
Vitamin D for health: a global perspective. Mayo Clin Proc (2013) 2.41
Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys (2007) 2.39
Unhealthy drinking patterns in older adults: prevalence and associated characteristics. J Am Geriatr Soc (2007) 2.38
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.37
Chronic care management for dependence on alcohol and other drugs: the AHEAD randomized trial. JAMA (2013) 2.36
A single-question screening test for drug use in primary care. Arch Intern Med (2010) 2.35
PTSD in urban primary care: high prevalence and low physician recognition. J Gen Intern Med (2007) 2.22
Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol (2007) 2.20
Plasma 25-hydroxyvitamin D levels in young children undergoing placement of tympanostomy tubes. Ann Otol Rhinol Laryngol (2008) 2.13
A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc (2007) 2.12
Screening and brief intervention online for college students: the ihealth study. Alcohol Alcohol (2006) 2.06
Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Ann Intern Med (2013) 2.04
Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol (2005) 2.01
Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res (2011) 2.00
Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med (2008) 1.98
Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr (2010) 1.97
Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab (2007) 1.96
Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction (2004) 1.88
Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr (2005) 1.88
Physician education in addiction medicine. JAMA (2013) 1.87
Treating homeless opioid dependent patients with buprenorphine in an office-based setting. J Gen Intern Med (2007) 1.84
Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. PLoS One (2010) 1.83
Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients (2013) 1.81
Too little vitamin D in premenopausal women: why should we care? Am J Clin Nutr (2002) 1.79
Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr (2004) 1.79
Do brief alcohol motivational interventions work like we think they do? Alcohol Clin Exp Res (2013) 1.78
Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness. Pediatrics (2010) 1.76
Synthesis of vitamin D in skin after burns. Lancet (2004) 1.75
Adolescent girls in Maine are at risk for vitamin D insufficiency. J Am Diet Assoc (2005) 1.74
Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med (2009) 1.73
A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab (2010) 1.69
Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children. Obesity (Silver Spring) (2008) 1.69
Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab (2004) 1.67
Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr (2009) 1.66
Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep (2010) 1.64
Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction (2007) 1.62
Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab (2008) 1.61
Vitamin D intake in the United States. J Am Diet Assoc (2004) 1.58
Mechanisms of change in control group drinking in clinical trials of brief alcohol intervention: implications for bias toward the null. Drug Alcohol Rev (2010) 1.56
Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med (2006) 1.56
Age of alcohol-dependence onset: associations with severity of dependence and seeking treatment. Pediatrics (2006) 1.55
Impact of U.S. citizenship status on cancer screening among immigrant women. J Gen Intern Med (2005) 1.55
Addressing alcohol problems in primary care: a cluster randomized, controlled trial of a systems intervention. The screening and intervention in primary care (SIP) study. Ann Intern Med (2003) 1.54
Methadone dose, take home status, and hospital admission among methadone maintenance patients. J Addict Med (2012) 1.53
Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med (2011) 1.53
The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making (2010) 1.51
No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use. J Gen Intern Med (2013) 1.49
Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab (2011) 1.49
Prenatal and early childhood exposure to tetrachloroethylene and adult vision. Environ Health Perspect (2012) 1.49
Deficiency of sunlight and vitamin D. BMJ (2008) 1.49
The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila) (2012) 1.48
Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an Internet-based study. Gastrointest Endosc (2007) 1.47
The mixed evidence for brief intervention in emergency departments, trauma care centers, and inpatient hospital settings: what should we do? Alcohol Clin Exp Res (2010) 1.47
Burden of medical illness in drug- and alcohol-dependent persons without primary care. Am J Addict (2004) 1.46
Correlating pre-operative vitamin d status with post-thyroidectomy hypocalcemia. Endocr Pract (2014) 1.45
The use of the mini-mental state examination in recruitment for substance abuse research studies. Drug Alcohol Depend (2005) 1.45
Professional satisfaction experienced when caring for substance-abusing patients: faculty and resident physician perspectives. J Gen Intern Med (2002) 1.45
The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev (2012) 1.44
Do brief measures of readiness to change predict alcohol consumption and consequences in primary care patients with unhealthy alcohol use? Alcohol Clin Exp Res (2007) 1.44
Sex trafficking and initiation-related violence, alcohol use, and HIV risk among HIV-infected female sex workers in Mumbai, India. J Infect Dis (2011) 1.43
Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective. J Gen Intern Med (2006) 1.41
Primary medical care and reductions in addiction severity: a prospective cohort study. Addiction (2005) 1.40
The severity of unhealthy alcohol use in hospitalized medical patients. The spectrum is narrow. J Gen Intern Med (2006) 1.38
Relationship between sleep position and risk of extreme cardiorespiratory events. J Pediatr (2012) 1.38
Review of treatment modalities for postmenopausal osteoporosis. South Med J (2005) 1.37
Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3. Carcinogenesis (2004) 1.37
Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr (2003) 1.36
The case for chronic disease management for addiction. J Addict Med (2008) 1.36
Alcohol use and HIV risk behaviors among HIV-infected hospitalized patients in St. Petersburg, Russia. Drug Alcohol Depend (2005) 1.36